TRAP® Discovered Pipeline of Small Molecule Drug Candidates
	Therapeutic Area	Mode of Action			Status
	Cancer	Tetravalent Alkylator			Pre-IND Studies
		Dual Aurora-VEGFR kinase			IND Candidate Selection
		VEGFR2			In vivo Proof of Concept Achieved
		Tubulin			In vivo Proof of Concept Achieved
	Multiple Sclerosis	Chemokine			Out-licensed
	Diabetes	IRK			Out-licensed

For further licensing information, please contact:

Steven R. Schow, Ph.D.
Vice President, Research and Development
Telik, Inc.
2100 Geng Road, Suite 102
Palo Alto, CA 94303
Tel: +1 (650) 845-7700
Fax: +1 (650) 845-7800
E-Mail: BusinessDev@telik.com

Home | About Telik | Research | Clinical Trials | Investor Info | Careers | Contact | Sitemap | Legal Notice

2100 Geng Road, Suite 102, Palo Alto, CA 94303Tel 650-845-7700Fax 650-845-7800
©2010 Telik, Inc. All rights reserved.